The prostate cancer screening clinic in the Bahamas: a model for low- and middle-income countries

被引:8
作者
Roberts, Robin [1 ]
Mitchell, Corydon [2 ]
Tancawan, Ana Lourdes [3 ]
Pedican, Mandi [3 ]
Jones, Glenn Wayne [4 ]
机构
[1] Univ West Indies, Sch Clin Med & Res, Shirley St,POB GT 2590, Nassau, Bahamas
[2] Us TOO Grand Bahama Prostate Canc Support Grp, POB F-1070, Freeport, Grand Bahama, Bahamas
[3] Rand Mem Hosp Grand Bahama Hlth Serv, Dept Pathol, East Mall Dr,POB F-40071, Freeport, Grand Bahama, Bahamas
[4] Partners Clin Res Ctr, 72 Collins Ave,POB N-4296, Nassau, Bahamas
关键词
Prostate cancer; Community-based screening; Lower-income countries; RADICAL PROSTATECTOMY; ACTIVE SURVEILLANCE; ANTIGEN;
D O I
10.1007/s10552-017-0972-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Grand Bahama (pop. 51,000) is an island within the Bahamas archipelago. A local chapter of International Us TOO Prostate Cancer Support Group (UTGB) has led an annual community-based prostate cancer screening clinic in Grand Bahama each September since 2009. Features of this initiative, characteristics of attendees, and a description of found cancers were summarized to determine the clinic's value and to guide improvements. Method We analyzed the established clinic from 2012 to 2015, wherein UTGB attracted corporate funding, volunteers managed clinics, and health professionals provided healthcare services. An explicit algorithm was used to sort clients by age, comorbidities, and findings from digital rectal examinations, and prostate-specific antigen (PSA) values, to determine which clients would undergo secondary assessment and prostate biopsy. Results Overall, 1,844 males were registered (mean age 57.6 years), and only 149 men attended on more than one occasion for a total of 1,993 clinic visit. The urologist reviewed 315 men in secondary follow-up, for elevated PSA and/or an abnormal digital rectal examination. Of these, 45 men fulfilled criteria for trans-rectal ultrasound biopsy, and there were 40 found cases of prostate cancer, for a positive-predictive value of 89%. By D'Amico risk-stratification, these 40 cases were low (10%), intermediate (40%), and high risk (50%). The urologist counseled all 40 cases and facilitated access to standard care. Conclusion This study suggests that low-resource countries can advance cost-effective screening clinics, apply policy guidelines, and provide services within acceptable standards of care. It is the expectation, with a sustained effort and community participation over the ensuing years, that earlier disease presentation will occur and, consequently, a concomitant decrease in the disease-specific mortality.
引用
收藏
页码:1187 / 1193
页数:7
相关论文
共 29 条
  • [1] Ahmad S, 2011, CAN J UROL, V18, P6025
  • [2] Screening for Prostate Cancer - The Controversy That Refuses to Die
    Barry, Michael J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) : 1351 - 1354
  • [3] Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
    Bill-Axelson, Anna
    Holmberg, Lars
    Ruutu, Mirja
    Garmo, Hans
    Stark, Jennifer R.
    Busch, Christer
    Nordling, Stig
    Haggman, Michael
    Andersson, Swen-Olof
    Bratell, Stefan
    Spangberg, Anders
    Palmgren, Juni
    Steineck, Gunnar
    Adami, Hans-Olov
    Johansson, Jan-Erik
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (18) : 1708 - 1717
  • [4] What the US Preventive Services Task Force Missed in Its Prostate Cancer Screening Recommendation
    Catalona, William J.
    D'Amico, Anthony V.
    Fitzgibbons, William F.
    Kosoko-Lasaki, Omofolasade
    Leslie, Stephen W.
    Lynch, Henry T.
    Moul, Judd W.
    Rendell, Marc S.
    Walsh, Patrick C.
    [J]. ANNALS OF INTERNAL MEDICINE, 2012, 157 (02) : 137 - +
  • [5] Cheng Wai C., 2004, Int. braz j urol., V30, P466, DOI 10.1590/S1677-55382004000600003
  • [6] Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Blank, K
    Broderick, GA
    Tomaszewski, JE
    Renshaw, AA
    Kaplan, I
    Beard, CJ
    Wein, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11): : 969 - 974
  • [7] Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers
    Filella, Xavier
    Foj, Laura
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (11)
  • [8] Foley RW, 2017, AME MED J, DOI [10.21037/amj.2017.03.06, DOI 10.21037/AMJ.2017.03.06]
  • [9] 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
    Hamdy, F. C.
    Donovan, J. L.
    Lane, J. A.
    Mason, M.
    Metcalfe, C.
    Holding, P.
    Davis, M.
    Peters, T. J.
    Turner, E. L.
    Martin, R. M.
    Oxley, J.
    Robinson, M.
    Staffurth, J.
    Walsh, E.
    Bollina, P.
    Catto, J.
    Doble, A.
    Doherty, A.
    Gillatt, D.
    Kockelbergh, R.
    Kynaston, H.
    Paul, A.
    Powell, P.
    Prescott, S.
    Rosario, D. J.
    Rowe, E.
    Neal, D. E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (15) : 1415 - 1424
  • [10] EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent-Update 2013
    Heidenreich, Axel
    Bastian, Patrick J.
    Bellmunt, Joaquim
    Bolla, Michel
    Joniau, Steven
    van der Kwast, Theodor
    Mason, Malcolm
    Matveev, Vsevolod
    Wiegel, Thomas
    Zattoni, F.
    Mottet, Nicolas
    [J]. EUROPEAN UROLOGY, 2014, 65 (01) : 124 - 137